Skip to main content
logo
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
19.02
-0.34 (-1.76%)
Jul 24, 2026, 4:00 PM EDT - Market closed

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,5719413,4163,65240933
Market Cap Growth
-55.59%-72.46%-6.46%792.23%1152.09%-29.13%
Enterprise Value
1,314622.442,9773,162357.339.72
Last Close Price
19.0213.1854.1560.3910.509.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.403.097.647.378.370.78
P/TBV Ratio
4.992.797.625.998.152.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.240.000.000.000.36
Net Debt / Equity Ratio
-1.01-1.04-1.00-1.02-1.470.17
Net Debt / EBITDA Ratio
0.971.313.149.441.11-
Net Debt / FCF Ratio
1.151.623.8011.781.29-11.39
Quick Ratio
7.898.7720.0751.389.440.39
Current Ratio
8.609.2721.1151.599.980.46
Return on Equity (ROE)
-92.92%-60.78%-25.08%-15.14%-116.47%0.00%
Return on Assets (ROA)
-65.10%-54.41%-28.56%-17.98%-150.47%0.00%
Return on Invested Capital (ROIC)
---1995.52%-3482.20%-283.69%0.00%
Return on Capital Employed (ROCE)
-72.93%-58.68%-29.44%-18.48%-225.23%0.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-5.48%-2.53%-27.99%-29.46%-252.97%-165.00%
Total Shareholder Return
-5.48%-2.53%-27.99%-29.46%-252.97%-165.00%
SEC Filings: 10-K · 10-Q